Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators·2001·New England Journal of Medicine
DOI 10.1056/nejmoa010746

Cited by (1,007)

Items 101–200 of 1,007

  1. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
    Jean‐Philippe Collet, Jean‐Sébastien Hulot, Anna Pena, Eric Villard, Jean-Baptiste Estève, Johanne Silvain, Laurent Payot, Delphine Brugier, Guillaume Cayla, Farzin Beygui et al. · 2008 · The Lancet
  2. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
    Sacco, Ralph L., Diener, Hans-Christoph, Yusuf, Salim, Cotton, Daniel, Ôunpuu, Stephanie, Lawton, William A., Palesch, Yuko, Martin, Reneé H., Albers, Gregory W., Bath, Philip et al. · 2008 · New England Journal of Medicine
  3. Platelet-Active Drugs
    Carlo Patrono, Barry S. Coller, James E. Dalen, Garret A. Fitz Gerald, Valentı́n Fuster, Michael Gent, Jack Hirsh, Gerald J. Roth · 2001 · CHEST Journal
  4. Variability in Individual Responsiveness to Clopidogrel
    Dominick Joseph Angiolillo, Antonio Fernández‐Ortíz, Esther Bernardo, Fernándo Alfonso, Carlos Macaya, Theodore A. Bass, Marco Antonio Costa · 2007 · Journal of the American College of Cardiology
  5. 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    Jeffrey L. Anderson, Cynthia D. Adams, Elliott Marshall Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin et al. · 2013 · Journal of the American College of Cardiology
  6. Vorapaxar in the Secondary Prevention of Atherothrombotic Events
    David A. Morrow, Eugene Braunwald, Marc P. Bonaca, Sebastián F. Ameriso, Anthony J. Dalby, Polly Fish, Keith A.A. Fox, Leslie Lipka, Xuan Liu, José Carlos Nicolau et al. · 2012 · New England Journal of Medicine
  7. Antithrombotic Therapy for Atrial Fibrillation
    Gregory Y.H. Lip, Amitava Banerjee, Giuseppe Boriani, Chern En Chiang, Ramiz A. Fargo, Ben Freedman, Deirdre A. Lane, Christian Thomas Ruff, Mintu P. Turakhia, David John Werring et al. · 2018 · CHEST Journal
  8. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research
    Philippe Généreux, Nicolò Piazza, Maria C. Alu, Tamim M. Nazif, Rebecca Tung Hahn, Philippe Pîbarot, Jeroen Joost Bax, Jonathon A Leipsic, Philipp Blanke, Eugene H. Blackstone et al. · 2020 · European Heart Journal
  9. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
    Jean‐Sébastien Hulot · 2006 · Blood
  10. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
    Lori J. Mosca, Lawrence J. Appel, Emelia J. Benjamin, Kathy A. Berra, Nisha Chandra‐Strobos, Rosalind P. Fabunmi, Deborah G. Grady, Constance K. Haan, Sharonne N. Hayes, Debra R. Judelson et al. · 2004 · Circulation
  11. Antithrombotic Therapy for Atrial Fibrillation
    John J. You, Daniel E. Singer, Patricia A Howard, Deirdre A. Lane, Mark H. Eckman, Margaret C. Fang, Elaine M. Hylek, Sam Schulman, Alan S. Go, Michael Hughes et al. · 2012 · CHEST Journal
  12. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication
    Michael S. Conte, Frank B. Pomposelli, Daniel G. Clair, Patrick J. Geraghty, James F. McKinsey, Joseph L. Mills, Gregory L. Moneta, Mohammad Hassan Murad, Richard J. Powell, Amy B. Reed et al. · 2015 · Journal of Vascular Surgery
  13. Acute Coronary Care in the Elderly, Part I
    Karen P. Alexander, Laura Kristin Newby, Christopher Paul Cannon, Paul W. Armstrong, W. Brian Gibler, Michael W. Rich, Frans Van de Werf, Harvey Douglas White, W. Douglas Weaver, Mary Duffin Naylor et al. · 2007 · Circulation
  14. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
    Sidney C. Smith, Emelia J. Benjamin, Robert O. Bonow, Lynne T. Braun, Mark A. Creager, Barry A. Franklin, Raymond J. Gibbons, Scott M. Grundy, Loren F. Hiratzka, Daniel W. Jones et al. · 2011 · Journal of the American College of Cardiology
  15. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
    Michel E. Bertrand · 2002 · European Heart Journal
  16. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article
    Kim A. Eagle, Robert A. Guyton, Ravin Davidoff, Fred H. Edwards, Gordon A. Ewy, Timothy J. Gardner, James C. A. Hart, Howard C. Herrmann, L. David Hillis, Adolph M. Hutter et al. · 2004 · Circulation
  17. Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement
    John A. Spertus, Richard Kettelkamp, Clifton Vance, Carole Decker, Philip G. Jones, John S. Rumsfeld, John C. Messenger, Sanjaya Khanal, Eric David Peterson, Richard G. Bach et al. · 2006 · Circulation
  18. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
    Fihn, Stephan D., Gardin, Julius M., Abrams, Jonathan, Berra, Kathleen, Blankenship, James C., Dallas, Apostolos P., Douglas, Pamela S., Foody, JoAnne M., Gerber, Thomas C., Hinderliter, Alan L. et al. · 2012 · Circulation
  19. ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article
    Eugene Braunwald M. D, Elliott Marshall Antman, John Wagner Beasley, Robert M. Califf, Melvin D. Cheitlin, Judith S. Hochman, Robert H. Jones, Dean J. Kereiakes, Joel Kupersmith, Thomas N. Levin et al. · 2002 · Circulation
  20. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
    Deepak L. Bhatt, James M. Scheiman, Neena S. Abraham, Elliott Marshall Antman, Francis K.L. Chan, Curt Daniel Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M.M. Quigley · 2008 · Circulation
  21. Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome
    Keith A.A. Fox, Shamir R. Mehta, Ron J.G. Peters, Feng Zhao, Nasser M. Lakkis, Bernard John Gersh, Salim Yusuf · 2004 · Circulation
  22. European Resuscitation Council Guidelines for Resuscitation 2005
    Jasmeet Soar, Charles D. Deakin, Jerry P. Nolan, Gamal Abbas, Annette V.M. Alfonzo, Anthony J. Handley, David Lockey, Gavin D. Perkins, Karl‐Christian Thies · 2005 · Resuscitation
  23. The Perioperative Management of Antithrombotic Therapy
    James Demetrios Douketis, Peter B. Berger, Andrew S Dunn, Amir K. Jaffer, Alex C. Spyropoulos, Richard Clinton Becker, Jack Ansell · 2008 · CHEST Journal
  24. Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes
    Shamir R. Mehta, Christopher Paul Cannon, Keith A.A. Fox, Lars C. Wallentin, William E. Boden, R Spacek, Petr Widimský, Peter Andrew McCullough, David U. Hunt, Eugene Braunwald et al. · 2005 · JAMA
  25. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
    Shamir R. Mehta, Jean‐François Tanguay, John W. Eikelboom, Sanjit S. Jolly, Campbell D. Joyner, Christopher Bull Granger, David P. Faxon, Hans‐Jürgen Rupprecht, Andrzej Budaj, Álvaro Avezum et al. · 2010 · The Lancet
  26. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
    L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter et al. · 2011 · Journal of the American College of Cardiology
  27. Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial
    Deepak L. Bhatt, Marcus D Flather, Werner Hacke, Peter B. Berger, Henry Richard Black, William E. Boden, P. Cacoub, Eric A. Cohen, Mark A. Creager, J. Donald Easton et al. · 2007 · Journal of the American College of Cardiology
  28. Diagnosis and Treatment of Acute Coronary Syndromes
    Deepak L. Bhatt, Renato D. Lópes, Robert A. Harrington · 2022 · JAMA
  29. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
    L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter et al. · 2011 · Circulation
  30. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
    Ezra A. Amsterdam, NANETTE KASS WENGER, Ralph G. Brindis, Donald E. Casey, Théodore G. Ganiats, David R. Holmes, Allan S. Jaffe, Hani M. Jneid, Rosemary F. Kelly, Michael Christopher Kontos et al. · 2014 · Journal of the American College of Cardiology
  31. Variability in platelet responsiveness to clopidogrel among 544 individuals
    Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger, Alex I. Malinin, Deepak L. Bhatt, Eric J. Topol · 2005 · Journal of the American College of Cardiology
  32. Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
    The CURRENT–OASIS 7 Investigators · 2010 · New England Journal of Medicine
  33. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
    David Nelson Juurlink, Tara Gomes, Dennis T. Ko, Paul E. Szmitko, Peter C. Austin, Jack V. Tu, David A Henry, Alex Kopp, Muhammad Mamdani · 2009 · Canadian Medical Association Journal
  34. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel–Thrombolysis in Myocardial Infarction 38
    Wiviott, Stephen D., Braunwald, Eugene, Angiolillo, Dominick J., Meisel, Simha, Dalby, Anthony J., Verheugt, Freek W.A., Goodman, Shaun G., Corbalan, Ramon, Purdy, Drew A., Murphy, Sabina A. et al. · 2008 · Circulation
  35. Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
    Pierluigi Tricoci, Zhen Huang, Claes Held, David J. Moliterno, Paul W. Armstrong, Frans Van de Werf, Harvey Douglas White, Philip E. Aylward, Lars C. Wallentin, Edmond Chen et al. · 2011 · New England Journal of Medicine
  36. Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection
    Hugh Stephen Markus, Dirk Wolfgang Droste, Manfred Kaps, Vincent Larrue, Kennedy R. Lees, Mario Siebler, E. Bernd Ringelstein · 2005 · Circulation
  37. Antiplatelet Drugs
    Carlo Patrono, Colin Baigent, Jack Hirsh, Gerald J. Roth · 2008 · CHEST Journal
  38. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
    Steen Husted, Håkan Emanuelsson, Stan Heptinstall, Per Morten Sandset, Mark Wickens, Gary R. Peters · 2006 · European Heart Journal
  39. Drug-Eluting Coronary-Artery Stents
    Giulio Giuseppe Stefanini, David R. Holmes · 2013 · New England Journal of Medicine
  40. Coronary Intervention for Persistent Occlusion after Myocardial Infarction
    Judith S. Hochman, Gervasio A. Lamas, Christopher E.H. Buller, Vladimír Džavík, Harmony R. Reynolds, Staci Abramsky, Sandra A. Forman, Witold Rużyłło, Aldo Pietro Maggioni, Harvey Douglas White et al. · 2006 · New England Journal of Medicine
  41. Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
    John T. Brandt, Sandra L. Close, Stephen J. Iturria, Christopher D. Payne, N.A. FARID, C. Steven Ernest, David Richard Lachno, Daniel E. Salazar, Kenneth J. Winters · 2007 · Journal of Thrombosis and Haemostasis
  42. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary
    Ian M Graham · 2007 · Atherosclerosis
  43. Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes
    Ron J.G. Peters, Shamir R. Mehta, Keith A.A. Fox, Feng Zhao, Basil S. Lewis, Steven L. Kopecky, Rafael Díaz, Patrick Commerford, Vicent Valentín, Salim Yusuf · 2003 · Circulation
  44. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
    Joep Perk, Guy De Backer, H. Gohlke, Ian M Graham, Željko Reiner, W. M. Monique Verschuren, Christian Albus, Pascale Benlian, Gudrun Boysen, Renata Cífková et al. · 2012 · Atherosclerosis
  45. Troponin: the biomarker of choice for the detection of cardiac injury
    Luciano Babuin, Allan S. Jaffe · 2005 · Canadian Medical Association Journal
  46. Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
    Wei C. Lau, Lucy A. Waskell, Paul Brent Watkins, Charlene J. Neer, Kevin Horowitz, Amy S. Hopp, Alan R. Tait, David G.M. Carville, Kirk E. Guyer, Eric Bates · 2003 · Circulation
  47. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
    J. L. Mega, Eugene Braunwald M. D, Satishkumar Mohanavelu, Paul B.J. Burton, Rohan S. Poulter, Frank Misselwitz, Vasil Hricak, E.S. Barnathan, Pascual Bordes, Adam Witkowski et al. · 2009 · The Lancet
  48. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke
    The SPS3 Investigators · 2012 · New England Journal of Medicine
  49. Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non–ST-Segment Elevation Acute Coronary Syndromes
    Karen P. Alexander · 2005 · JAMA
  50. Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
    Carlo Patrono, Barry S. Coller, Garret A. FitzGerald, Jack Hirsh, Gerald J. Roth · 2004 · CHEST Journal
  51. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
    Christopher Paul Cannon, Robert A. Harrington, Stefan Karl James, Diego Ardissino, Richard Clinton Becker, Håkan Emanuelsson, Steen Husted, Hugo Albert Katus, Mátyás Keltai, Nardev Singh Khurmi et al. · 2010 · The Lancet
  52. Platelet-neutrophil-interactions: Linking hemostasis and inflammation
    Alexander Zarbock, Renata Polanowska‐Grabowska, Klaus F. Ley · 2006 · Blood Reviews
  53. Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
    Gilles Montalescot, Leonardo Bolognese, Dariusz Dudek, Patrick Goldstein, Christian W. Hamm, Jean‐François Tanguay, Jurriën M. ten Berg, Debra Lee Miller, Timothy M. Costigan, Jochen Gödicke et al. · 2013 · New England Journal of Medicine
  54. Intravenous Platelet Blockade with Cangrelor during PCI
    Deepak L. Bhatt, Abraham Michael Lincoff, Charles Michael Gibson, Gregg W. Stone, Steven E. McNulty, Gilles Montalescot, Neal S. Kleiman, Shaun G. Goodman, Harvey Douglas White, Kenneth W. Mahaffey et al. · 2009 · New England Journal of Medicine
  55. A New Strategy for Discontinuation of Dual Antiplatelet Therapy
    Byeong‐Keuk Kim, Myeong‐Ki Hong, Dong‐Ho Shin, Chung Mo Nam, Jung‐Sun Kim, Young‐Guk Ko, Donghoon Choi, Tae Soo Kang, Byoung‐Eun Park, Woong Chol Kang et al. · 2012 · Journal of the American College of Cardiology
  56. Biomarkers in Acute Cardiac Disease
    Allan S. Jaffe, Luciano Babuin, Fred S. Apple · 2006 · Journal of the American College of Cardiology
  57. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack
    Peter Malcolm Rothwell, MF Giles, Enrico Floßmann, CE Lovelock, J.N.E. Redgrave, C P Warlow, Z Mehta · 2005 · The Lancet
  58. Platelet Inhibition with Cangrelor in Patients Undergoing PCI
    Robert A. Harrington, Gregg W. Stone, Steven E. McNulty, Harvey Douglas White, Abraham Michael Lincoff, Charles Michael Gibson, Charles V. Pollack, Gilles Montalescot, Kenneth W. Mahaffey, Neal S. Kleiman et al. · 2009 · New England Journal of Medicine
  59. Clopidogrel versus Aspirin and Esomeprazole to Prevent Recurrent Ulcer Bleeding
    Francis K.L. Chan, Jessica Y. L. Ching, Lawrence C.T. Hung, Vincent Wai‐Sun Wong, Vincent K S Leung, Nelson N.S. Kung, Aric Josun Hui, Justin C.Y. Wu, Wai K. Leung, Vivian Wing Yan Lee et al. · 2005 · New England Journal of Medicine
  60. Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)
    JBS3 Board · 2014 · Heart
  61. Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
    Hyeon‐Cheol Gwon, Joo‐Yong Hahn, Kyung Woo Park, Young Bin Song, In‐Ho Chae, Do‐Sun Lim, Kyoo‐Rok Han, Jin‐Ho Choi, Seung‐Hyuk Choi, Hyun‐Jae Kang et al. · 2011 · Circulation
  62. Genomics and Drug Response
    Liewei Wang, Howard L. McLeod, Richard M. Weinshilboum · 2011 · New England Journal of Medicine
  63. Pathophysiology and Therapeutic Potential of Purinergic Signaling
    Geoffrey Burnstock · 2006 · Pharmacological Reviews
  64. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary
    L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter et al. · 2011 · Circulation
  65. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
    Spencer B. King, Sidney C. Smith, John Winslow Hirshfeld, Douglass A. Morrison, David O. Williams, Alice K. Jacobs · 2008 · Journal of the American College of Cardiology
  66. Acute myocardial infarction
    Harvey Douglas White, Derek P. Chew · 2008 · The Lancet
  67. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)
    Lars Rydén, Peter J. Grant, Stefan D. Anker, Christian Berne, Francesco Cosentino, Nicolas Danchin, Christi Deaton, Javier Escaned, Hans‐Peter Hammes, Heikki Huikuri et al. · 2014 · Revista Española de Cardiología (English Edition)
  68. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
    Claudio Rapezzi, Elena Biagini, Angelo Branzi · 2007 · European Heart Journal
  69. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Rao, Sunil V., O’Donoghue, Michelle L., Ruel, Marc, Rab, Tanveer, Tamis-Holland, Jaqueline E., Alexander, John H., Baber, Usman, Baker, Heather, Cohen, Mauricio G., Cruz-Ruiz, Mercedes et al. · 2025 · Circulation
  70. Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
    Dirk Sibbing, Werner Koch, Daniela Gebhard, Tibor Schuster, Siegmund Braun, Julia Stegherr, Tanja Morath, Albert Schömig, Nicolas von Beckerath, Adnan Kastrati · 2010 · Circulation
  71. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
    Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh G Calkins, Elliot L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten et al. · 2007 · Circulation
  72. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
    Sunil V. Rao, Michelle L. O’Donoghue, Marc Ruel, Tanveer Rab, Jaqueline E. Tamis-Holland, John Hunter Alexander, Usman Baber, Heather Baker, Mauricio G. Cohen, Mercedes Cruz-Ruiz et al. · 2025 · Journal of the American College of Cardiology
  73. ESVS Guidelines. Invasive Treatment for Carotid Stenosis: Indications, Techniques
    Christos D. Liapis, Sir Peter Bell, Dimitri P. Mikhailidis, Juhani Sivenius, Andrew N Nicolaides, José Fernandes e Fernandes, G Biasi, Lars Norgren · 2009 · European Journal of Vascular and Endovascular Surgery
  74. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
    Rikke Sørensen, Morten Lock Hansen, Steen Zabell Abildstrom, Anders Hvelplund, Charlotte Andersson, Casper H. Jørgensen, Jan Kyst Madsen, Peter Riis Hansen, Lars Køber, Christian Tobias Torp-Pedersen et al. · 2009 · The Lancet
  75. Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
    Deepak L. Bhatt, Matthew T. Roe, Eric David Peterson, Yun Li, Anita Y. Chen, Robert A. Harrington, Adam B. Greenbaum, Peter B. Berger, Christopher Paul Cannon, David J. Cohen et al. · 2004 · JAMA
  76. JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
    Kimura, Kazuo, Kimura, Takeshi, Ishihara, Masaharu, Nakagawa, Yoshihisa, Nakao, Koichi, Miyauchi, Katsumi, Sakamoto, Tomohiro, Tsujita, Kenichi, Hagiwara, Nobuhisa, Miyazaki, Shunichi et al. · 2019 · Circulation Journal
  77. Prevention of Heart Failure
    Douglas D. Schocken, Emelia J. Benjamin, Gregg C. Fonarow, Harlan M. Krumholz, Daniel A Levy, George A. Mensah, Jagat Narula, Eileen Stuart‐Shor, James B. Young, Yuling Hong · 2008 · Circulation
  78. Benefit of Early Invasive Therapy in Acute Coronary Syndromes
    Anthony A. Bavry, Dharam J. Kumbhani, Andrew N. Rassi, Deepak L. Bhatt, Arman T. Askari · 2006 · Journal of the American College of Cardiology
  79. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
    Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno et al. · 2021 · European Journal of Preventive Cardiology
  80. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
    Claes Held, Nils Åsenblad, Jean Pierre Bassand, Richard Clinton Becker, Christopher Paul Cannon, Marc J. Claeys, Robert A. Harrington, Jay Charles Horrow, Steen Husted, Stefan Karl James et al. · 2010 · Journal of the American College of Cardiology
  81. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
    Ralph L. Sacco, Robert J. Adams, Gregory W. Albers, Mark J. Alberts, Oscar Benavente, Karen L. Furie, Larry B. Goldstein, Philip B. Gorelick, Jonathan L. Halperin, Robert E. Harbaugh et al. · 2006 · Circulation
  82. Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment
    Dominick Joseph Angiolillo, Antonio Fernández‐Ortíz, Esther Bernardo, Celia Ramírez, Manel Sabaté, Pilar Jiménez‐Quevedo, Rosana Hernández, Raúl Moreno, Javier Escaned, Fernándo Alfonso et al. · 2005 · Diabetes
  83. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
    Tomas Jernberg, Christopher D. Payne, Kenneth J. Winters, Christelle Darstein, John T. Brandt, Joseph A. Jakubowski, Hideo Naganuma, Agneta G Siegbahn, Lars C. Wallentin · 2006 · European Heart Journal
  84. Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
    Guillaume Paré, Shamir R. Mehta, Salim Yusuf, Sonia Savitri Anand, Stuart J. Connolly, Jack Hirsh, Katy L. Simonsen, Deepak L. Bhatt, Keith A.A. Fox, John W. Eikelboom · 2010 · New England Journal of Medicine
  85. New Antithrombotic Drugs
    Jeffrey Ian Weitz, John W. Eikelboom, Meyer Michel Samama · 2012 · CHEST Journal
  86. Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes
    Robbert J. de Winter, Fons Windhausen, Jan Hein Cornel, Peter H.J.M. Dunselman, Charles L. Janus, Peter E.F. Bendermacher, H. R. Michels, Gerard T. Sanders, Jan G.P. Tijssen, Freek W.A. Verheugt · 2005 · New England Journal of Medicine
  87. Aspirin resistance
    Graeme J. Hankey, John W. Eikelboom · 2006 · The Lancet
  88. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
    Jonas Oldgren, Andrzej Budaj, Christopher Bull Granger, Yasser Khder, J. Roberts, Agneta Siegbahn, Jan G.P. Tijssen, Frans Van de Werf, Lars C. Wallentin, for the RE-DEEM Investigators · 2011 · European Heart Journal
  89. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
    Sidney C. Smith, Ted E Feldman, John Winslow Hirshfeld, Alice K. Jacobs, Morton J. Kern, Spencer B. King, Douglass A. Morrison, William W. O’Neill, Hartzell Vernon Schaff, Patrick L. Whitlow et al. · 2005 · Journal of the American College of Cardiology
  90. A Randomized Comparison of High Clopidogrel Loading Doses in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
    Gilles Montalescot, Georges Sideris, Catherine Meuleman, Claire Bal dit Sollier, Nicolas Lellouche, Philippe Gabríel Steg, Michel Slama, Olivier Milleron, Jean‐Philippe Collet, Patrick Henry et al. · 2006 · Journal of the American College of Cardiology
  91. Resistance to clopidogrel: A review of the evidence
    Thùy Anh Nguyễn, Jean Gino Diodati, Chantal Pharand · 2005 · Journal of the American College of Cardiology
  92. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Théodore G. Ganiats, Hani M. Jneid, Abraham Michael Lincoff et al. · 2011 · Journal of the American College of Cardiology
  93. Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
    Christopher Paul Cannon, Steen Husted, Robert A. Harrington, Benjamin M. Scirica, Håkan Emanuelsson, Gary R. Peters, Robert F. Storey · 2007 · Journal of the American College of Cardiology
  94. Acute coronary syndromes
    Brian A Bergmark, Njambi Mathenge, Piera A Merlini, Marilyn B Lawrence-Wright, Robert Patrick Giugliano · 2022 · The Lancet
  95. Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance
    Wei C. Lau, Paul Alfred Gurbel, Paul Brent Watkins, Charlene J. Neer, Amy S. Hopp, David G.M. Carville, Kirk E. Guyer, Alan R. Tait, Eric Bates · 2004 · Circulation
  96. 2016 European Guidelines on cardiovascular disease prevention in clinical practice
    Massimo Francesco Piepoli, Arno Wilhelmus Hoes, Stefan Agewall, Christian Albus, Carlos Brotons, Alberico Luigi Catapano, Marie Therese Cooney, Ugo Corrà, Bernard Cosyns, Christi Deaton et al. · 2016 · Atherosclerosis
  97. Complications of Proton Pump Inhibitor Therapy
    Michael Fredrick Vaezi, Yu‐Xiao Yang, Colin W. Howden · 2017 · Gastroenterology
  98. Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes
    Robert F. Storey, Steen Husted, Robert A. Harrington, Stanley Heptinstall, Robert G. Wilcox, Gary R. Peters, Mark Wickens, Håkan Emanuelsson, Paul Alfred Gurbel, Peer Grande et al. · 2007 · Journal of the American College of Cardiology
  99. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
    Duilio Pagano, Milan Milojevic, Michael Isaäc Meesters, Umberto Benedetto, Daniel Bolliger, Christian von Heymann, Anders Jeppsson, Andreas Koster, Ruben L.J. Osnabrugge, Marco Ranucci et al. · 2017 · European Journal of Cardio-Thoracic Surgery
  100. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease
    Bertil Lindahl, Tomasz Baron, David Erlinge, Nermin Hadziosmanovic, Anna E. Nordenskjöld, Anton Gard, Tomas Jernberg · 2017 · Circulation